Home Cart Sign in  
Chemical Structure| 170632-47-0 Chemical Structure| 170632-47-0

Structure of Lificiguat
CAS No.: 170632-47-0

Chemical Structure| 170632-47-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Lificiguat binds to the β subunit of soluble guanylyl cyclase (sGC) with a Kd of 0.6-1.1 μM in the presence of CO.

Synonyms: YC-1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Lificiguat

CAS No. :170632-47-0
Formula : C19H16N2O2
M.W : 304.34
SMILES Code : OCC1=CC=C(C2=NN(CC3=CC=CC=C3)C4=C2C=CC=C4)O1
Synonyms :
YC-1
MDL No. :MFCD06407798
InChI Key :OQQVFCKUDYMWGV-UHFFFAOYSA-N
Pubchem ID :5712

Safety of Lificiguat

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Lificiguat

epigenetics
GPCR

Isoform Comparison

Biological Activity

Target
  • HIF

In Vitro:

Cell Line
Concentration Treated Time Description References
Mesenchymal stem cells 100 μM 12 hours YC-1 blocked the protective effects of PGE1 preconditioning on mesenchymal stem cells and inhibited HIF-1α expression. PMC9288720
Human umbilical vein endothelial cells (HUVECs) 1 μmol/L 24 hours Inhibition of HIF-1α, reduction of YAP expression and transcriptional activity, and suppression of hypoxia-induced endothelial-to-mesenchymal transition (EndMT) in HUVECs PMC9091893

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rats Thalamic hemorrhagic stroke model Intra-thalamic injection 10 mg kg−1 once daily for 16 days Inhibiting HIF-1α/NLRP3 signaling to prevent mechanical allodynia and anxiety- and depression-like behaviors induced by thalamic hemorrhagic stroke PMC10031944
Rats Neonatal hypoxic-ischemic brain injury model Left lateral ventricle injection 1000 nM Single injection, lasting 10 hours Lificiguat, as an HIF-1α inhibitor, reversed the neuroprotection induced by sevoflurane postconditioning, indicating that sevoflurane alleviates astrogliosis and glial scar formation after hypoxic-ischemic brain injury by stabilizing HIF-1α expression. PMC8224129

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.29mL

0.66mL

0.33mL

16.43mL

3.29mL

1.64mL

32.86mL

6.57mL

3.29mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories